BRIEF published on 03/26/2026 at 14:23, 5 months 17 days ago RHÖN-KLINIKUM AG Reports Steady Progress in 2025 RHÖN-KLINIKUM AG Patient Growth Healthcare Investments 2026 Outlook 2025 Financial Results
PRESS RELEASE published on 03/26/2026 at 14:18, 5 months 17 days ago RHÖN-KLINIKUM AG with consistent development in financial year 2025 RHÖN-KLINIKUM AG reports consistent financial development in 2025 with revenue growth and increased patient numbers. Focus on medical high-tech and care structures Financial Results RHÖN-KLINIKUM AG Patient Growth Medical High-tech Care Structures
BRIEF published on 01/14/2026 at 16:57, 7 months 29 days ago RHÖN-KLINIKUM AG Revises 2025 EBITDA Forecast Downward EBITDA Forecast Healthcare Provider Cost Management RHÖN-KLINIKUM AG Financial Year 2025
BRIEF published on 01/14/2026 at 16:57, 7 months 29 days ago RHÖN-KLINIKUM AG révise à la baisse ses prévisions d'EBITDA pour 2025 Gestion Des Coûts Prévisions D'EBITDA RHÖN-KLINIKUM AG Exercice Financier 2025 Prestataire De Santé
PRESS RELEASE published on 01/14/2026 at 16:52, 7 months 29 days ago EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft adjusts the EBITDA forecast for financial year 2025 RHÖN-KLINIKUM Aktiengesellschaft adjusts EBITDA forecast for 2025 due to unforeseen business developments. Annual report planned on 26 March 2026 EBITDA Forecast Annual Report Business Developments Financial Year 2025 RHÖN-KLINIKUM Aktiengesellschaft
BRIEF published on 11/06/2025 at 09:05, 10 months 7 days ago RHÖN-KLINIKUM AG annonce de solides performances financières au troisième trimestre 2025 Résultats Financiers Croissance Des Revenus Secteur De La Santé RHÖN-KLINIKUM AG Hôpitaux En Allemagne
BRIEF published on 11/06/2025 at 09:05, 10 months 7 days ago RHÖN-KLINIKUM AG Reports Robust Q3 2025 Financial Performance Financial Results Revenue Growth Healthcare Sector RHÖN-KLINIKUM AG Germany Hospitals
PRESS RELEASE published on 11/06/2025 at 09:00, 10 months 7 days ago RHÖN-KLINIKUM AG closes third quarter of 2025 with solid results RHÖN-KLINIKUM AG reports solid results for Q3 2025 with revenue increase and stable equity ratio. Board focuses on consistent management amidst sector challenges in Germany Revenue Increase Equity Ratio RHÖN-KLINIKUM AG Q3 2025 Hospital Sector
BRIEF published on 08/07/2025 at 09:04, 1 year 1 month ago RHÖN-KLINIKUM AG Reports Stable First Half of 2025 Results Revenue Growth Market Conditions Financial Forecast Healthcare Challenges EBITDA Stability
BRIEF published on 08/07/2025 at 09:04, 1 year 1 month ago RHÖN-KLINIKUM AG publie des résultats stables pour le premier semestre 2025 Prévisions Financières Croissance Des Revenus Conditions Du Marché Stabilité De L'EBITDA Défis En Matière De Santé
Published on 09/12/2026 at 02:35, 1 day 10 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 13 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 15 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 19 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 18 hours 47 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 5 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 14 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 14 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 16 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 5 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 days 5 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 17 hours ago Availability of the 2026 Interim Financial Report
